Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Neonatology > Respiratory > Flashcards

Respiratory Flashcards

1
Q

All infants <30wks should automatically be started on CPAP in the DR

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Benefits of CPAP

A

-deters alveolar collapse
-increases end-expiratory lung volumes
-maintains functional residual capacity (FRC).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indications for nitric oxide

A

> 34wks, PaO2<100 on 100% O2 and OI >20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Literature suggests there is no difference in oxygenation response between 20 ppm and 5-6 ppm, though 20ppm is associated with an improved pulmonary-systemic blood flow ratio

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Response to nitric oxide

A

-PaO2 increase by >20mmHg or 20% from baseline
-increase O2 sats by 10%

**assess after 30mins

20/20/20 rule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

concerning methemoglobin level

A

If >5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Can begin weaning FiO2 after 4 hours of iNO by 5% per hour

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

fetal absorption of fluid

A
  1. 1/3 absorbed prenatally during labor
  2. 1/3 absorbed during vaginal delivery
  3. 1/3 absorbed after delivery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of fluid absorption

A

-Onset of labor, maternal epinephrine, and glucocorticoids activate the ENaC on the apical membranes of type II pneumocytes.
-Sodium in the alveolus is transported passively across the ENaC proteins which in turn is actively transported back to the interstitium by the Na+/K+-ATPase pump
-An osmotic gradient is created which allows chloride and water to follow and be absorbed into pulmonary circulation and lymphatics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

if placenta undergoes stress might increase innate steroid release for baby and result less severe RDS vs chorioamnioitis results in diffuse inflammation response and worsening RDS

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diabetes and surfactant

A

hyperglycemia and hyperinsulinemia can disrupt surfactant lipid and protein synthesis, causing delayed maturation in surfactant in IDM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TTN time frame

A

symptomatic for 12 to 24 hours, but signs may persist as long as 72 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

RDS peak time

A

48-72hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hyperoxia does not enhance pulmonary vasodilation-> increased free radius that increase pulmonary arterial contractility and impairs vasodilation effects of iNO

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Atelectotrauma

A

repeated alveoli deflation and decreased lung volumes

-look at flow volume loop should see immediate increase upon a breath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

volutrauma

A

inflation of lungs to volumes that approach the total lung capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

barotrauma

A

overinflation and shearing stressed due to high PIPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Minimal tidal volume: <1kg: 5ml/kg, >1kg: 4.5ml/kg

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

causes of pulmonary edema

A

-too much blood/fluid going to the lungs
-increase leaking at capillary (sepsis, hypoxemia, hypoxia, RDS)
-increase resistance to blood leaving lungs (TAPVR, tamponade)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Avoid caffeine in preterm infants likely to remain mechanically ventilated beyond 10 post natal days

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

CAP trial

A

The use of caffeine was associated with decreased risk of bronchopulmonary dysplasia (anti-inflammatory effect) and cerebral palsy at 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

VitA criteria

A

<28wks, >28wks + <1kg +needs for mechanical ventilation or supplemental oxygen at 24hrs of life
-outborn qualifies if first dose given by 96hrs of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Benefits of VitA

A

-reduce the incidence of death or BPD at 36 weeks
-reduction in oxygen requirement at one month of age and a marginal reduction in oxygen use at 36 weeks
-reductions in periventricular leukomalacia and any grade of ROP

24
Q

Early postnatal (<8days) corticosteroid treatment adverse effects

A

-gastrointestinal bleeding, intestinal perforation, hyperglycemia, hypertension, hypertrophic cardiomyopathy and growth failure.
- increased risk of abnormal neurological examination and cerebral palsy

25
Q

Late postnatal (>8days) DART therapy

A

may reduce neonatal mortality without significantly increasing the risk of adverse long-term neurodevelopmental outcomes

26
Q

Threshold for DART therapy

A

> 65% risk for BPD: lower risk for death or CP (less harm)
<35% risk for BPD: increase risk of death or CP, neurodevelopment impairment

27
Q

Causes of BPD

A

-Prematurity
-Positive pressure ventilation
-prolonged oxygen exposure-free oxygen radicals
-protracted use of ET tubes
-pulmonary edema (PDA, over hydration, delayed diuresis)
-pulmonary air leak (PTX, PIE)
-proinflammatory cascade

28
Q

these variable affect the growth and development of the lungs + injury->inflammation +
younger the infant at birth the higher change the lungs not develop properly since more development takes place outside womb

A
29
Q

Vit A mechanism

A

needed for lung growth and keep epithelial cells of respiratory tract functioning

30
Q

BPD outcomes

A

-more likely to have respiratory symptoms (WOB, wheezing, tachypnea)
-increase re-hospitalzization and infections
-neurodevelopmental delay (cognitive/motor)
-cor pulmonale 2/2 pulmonary hypertension
-growth failure

31
Q

goal of management in BPD

A

-once stability is met, reduce respiratory support and medications in a way that maintains stability and growth while avoiding unnecessary stress (affect levels of inflammation-> affect progress, growth, development)
-provide adequate respiratory support in all states to allow infant to grow, develop and slowly gain improving respiratory function

32
Q

PFTs for infants with severe BPD

A

-91% had obstructive or obstructive/restrictive mixed lung disease (obstruction was mostly moderate or severe)
-heterogenous lung disease (area of atelectasis, and hyperinflation)
-chronic airway inflammation
-dynamic airway collapse

33
Q

PIP settings for severe BPD

A

-higher PIP to overcomes increased airway resistance and allow recruitment
-should have good air exchange and visible chest rise correlates with good air flow

34
Q

Optimal Tidal Volume

A

-10-12mL/kg during stable states
-higher in inflammatory states. (15-18mL/kg).

35
Q

Lower rates and increase i-time

A

-supports lung recruitment and allow time for emptying

0.55-0.6: rr 25
0.6-0.65: rr 20
0.65-0.7: rr 18
0.8: rr 15

36
Q

Steady linear growth in severe BPD

A

-Has recently been shown to predict improved tolerance and success to respiratory support decreases
-improved survival, developmental outcomes

37
Q

A stable respiratory status generally
allows tolerance of movement (improve muscle tone/strength allows weaning of the ventilator), improving neuro-regulation and engagement, and steady linear growth.

A
38
Q

long-term use of diuretics and low mobility combined, substantially increases
the risk of poor bone mineralization

A
39
Q

high levels of NaCl replacements may lead to fluid retention

A
40
Q

management of severe BPD

A

-optimize vent
-inhaled steroids
-bronchodilators (75%/63% of obstructive/mixed group were responsive), improved airflow, decrease in needed PIP to delivery goal tidal volumes
-nutrition
-diuretics
-systemic steroids (acute source of inflammation, regain stability, 3-10 days prevent adrenal suppression)

41
Q

Recruitment, decrease V/Q mismatch, adequate air flow and emptying->less “air hunger”

A
42
Q

As inflammation subsides, and linear growth resumes, gradually see decreasing oxygen needs and improving C02.

A
43
Q

DART Trial

A

-faciliate extubation in preterm infants
-first 4-6 weeks of life

44
Q

Other factors to focus on when weaning medications in severe BPD

A
  • NAS score
    -impact of the stress of weaning on ability to maintain stability of respiratory status and engage with their environment
45
Q

Higher PEEP in severe BPD

A

-Can worsen ability to get air flow in due to more pressure must overcome
-can worsen the area of lung that is over inflated
-range: 8-9

46
Q

Using atelectasis, hyperinflation, and air trapping to assess rate and i_time

A

If atelectasis: drop the rate to give pressure more time to get air in
if hyperinflation or air trapping either drop the time or the rate

47
Q

The issue with high pressure support in distress

A

tachypneic and infant has large tidal volume (taking good breath plus high pressure support) leads to inadequate expiration time
-can sometimes give sedation and drop the PS to help
-goal: 10-14

47
Q

The issue with high pressure support in distress

A

tachypneic and infant has large tidal volume (taking good breath plus high pressure support) leads to inadequate expiration time
-can sometimes give sedation and drop the PS to help
-goal: 10-14

48
Q

lasix has ventilator (via prostaglandin pathway) and diuretic effects

A
49
Q

SUPPORT Trial

A

-CPAP vs surfactant and intubation
-No difference in death of BPD
-CPAP group:Less frequently required intubation or postnatal corticosteroids for bronchopulmonary dysplasia, required fewer days of mechanical ventilation, and were more likely to be alive and free from the need for mechanical ventilation by day 7
-Study support consideration of CPAP as an alternative to intubation and surfactant in preterm infants

50
Q

Prenatal growth of CPAM

A
  • increase in size until 26 – 28 weeks’ gestation
    -after many plateau or even decrease
51
Q

CVR (CPAM volume ratio) measurement, CPAM

A

-size of lung lesion in relation to size of baby (head circumference)
>1.6 increase risk for developing heart failure

52
Q

CPAM +hydrops

A

-large lesions shift the heart and impair venous return or compression of lymphatic structure-> fetal heart failure (hydrops-skin edema, pleural effusion, ascites, pericardial)

53
Q

Complications of CPAM

A

in utero: compression of lungs (lead to pulmonary hypoplasia), displacement heart, hydrops
infections, malignancy (pleuropulmonary blastoma)

54
Q

lungs grow best when they are expanded

A
55
Q

PPH can be due to increase vascular or increase flow

A
56
Q

PPHN worse in first 72hrs

A

Neonatology (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions